Brookfield Reinsurance (NYSE:BNRE) Stock Price Up 0.3% - Should You Buy?

Key Points

• BNRE shares rose 0.3% to $42.12 (intraday high $42.44) on volume of ~16,627 shares, a 160% increase versus the average daily volume of 6,394.
• The stock trades below its 50‑day ($44.10) and 200‑day ($47.82) moving averages and has a market cap of $6.13 billion with a high P/E of 145.25 and beta of 1.53.
• Brookfield Reinsurance is a Bermuda‑domiciled reinsurer sponsored by Brookfield Asset Management, providing property catastrophe, casualty, specialty lines and retrocession solutions through a mix of underwriting and capital‑markets strategies.

Brookfield Reinsurance Ltd. (NYSE:BNRE - Get Free Report)'s share price rose 0.3% during trading on Tuesday . The company traded as high as $42.44 and last traded at $42.12. Approximately 16,627 shares traded hands during mid-day trading, an increase of 160% from the average daily volume of 6,394 shares. The stock had previously closed at $41.98.

Brookfield Reinsurance Price Performance

The business has a 50 day moving average price of $44.10 and a 200 day moving average price of $47.82. The firm has a market capitalization of $6.13 billion, a P/E ratio of 145.25 and a beta of 1.53.

About Brookfield Reinsurance

Brookfield Reinsurance NYSE: BNRE is a Bermuda-domiciled reinsurer sponsored by Brookfield Asset Management. The company provides a range of risk transfer solutions, including property catastrophe, casualty, specialty lines and retrocession coverage. By combining underwriting expertise with diversified capital markets strategies, Brookfield Reinsurance aims to meet the needs of primary insurers, reinsurers and other institutional clients seeking tailored reinsurance capacity.

In its underwriting operations, Brookfield Reinsurance focuses on structuring programs across regions and perils, deploying both traditional reinsurance treaties and facultative placements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.